10668VYXEOSOpenPhase IB/II of CPX-351 as maintenance therapy in AML patients ineligible for bone marrow transplantation IST-20-11365; STUDY00003287NCT04990102Industrial; InstitutionalAdultTreatmentI/IILocalLeukemia, otherDoucette, KimberleyGeorgetown University Medical Center : Courtney Brown; Hackensack University Medical Center; Lombardi Comprehensive Cancer Center : Courtney Brown; University of PennsylvaniaVyxeos_maintenance_protocol_v2.0_Eligibility Checklist.docxLeukemiaOncology GroupLombardi Comprehensive Cancer Center (LCCC)17339Courtney BrownCourtney Browncb1974@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">&copy; 2026 Advarra, Inc.</a>